Yale University/Yale Cancer Center — New Haven, Connecticut

Yale University/Yale Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Yale University/Yale Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma Multiforme, Anaplastic Astrocytoma.

Sponsors: Tocagen Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University/Yale Cancer Center?

Yale University/Yale Cancer Center has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University/Yale Cancer Center conducted?

Yale University/Yale Cancer Center has 1 clinical trials on record. Their work covers Glioblastoma Multiforme, Anaplastic Astrocytoma.

Is Yale University/Yale Cancer Center accredited by Crixeo Health?

Yale University/Yale Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University/Yale Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.